Medical Oxygen Concentrators Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Portable Oxygen Concentrators and Stationary Oxygen Concentrators), By Technology (Pulse Dose Oxygen Concentrators and Continuous Flow Oxygen Concentrators), By Application (COPD, Asthma, Cystic Fibrosis, Pneumonia, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers (ASC), Homecare, and Travel Agents), and Region Forecast 2020-2031

Medical Oxygen Concentrators Market size was valued at US$ 2,148.6 million in 2024 and is expected to reach US$ 4,029.8 million by 2031, growing at a significant CAGR of 9.4% from 2025-2031. The market's growing geriatric population, the incidence of various respiratory disorders, and technology advances in oxygen concentrators. Oxygen concentrators are medical equipment that extract oxygen from a gas supply by selectively removing nitrogen, resulting in an oxygen-enriched product gas spurt. Oxygen concentrators are medical devices that selectively remove nitrogen from a gas supply, producing an oxygen-enriched product gas spurt. Air is circulated through molecular filter beds in oxygen concentrators to concentrate ambient oxygen to therapeutic levels for patient administration. Oxygen concentrators are used by patients who require supplemental oxygen for respiratory ailments such as bronchitis, emphysema, lung cancer, or acute pneumonia.

Oxygen concentrators can be used at home or in hospital settings to help users meet their oxygen needs. Because of their ease of use, oxygen concentrators are becoming increasingly popular and in high demand. Moreover, several oxygen concentrators are available with different flow rates such as continuous and pulse flow devices, which are digitally monitored to help in the improved usability in across patient groups in hospital and homecare setups, which are advancing medical revenue growth across the globe.  

Key Developments

• On January 27, 2025 - China-based Yuwell Medical recently held its 2025 Global Core Partner Conference in Dubai, and announced a strategic investment and partnership with Inogen, a leading US-based company in respiratory health, highlighting its joint commitment to advancing medical device solutions and deeper collaboration.
• On Jan. 17, 2025 - Inspira Technologies OXY B.H.N. Ltd., a leader in life-support technology innovation, has announced that the Company is establishing a dedicated production line for a crucial component of its innovative respiratory support system, in collaboration with Zriha Medical Ltd, a leading international manufacturer specializing in medical device production. The collaboration involves the manufacture of a flow mechanism that will be integrated into Inspira's products for use in the extracorporeal circulation of blood during the oxygenation process.